Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a White Round 11 mm, Tablet with imprint "M;253". It contains Acyclovir 400 mg; of Acyclovir[acyclovir];. This belongs to the Herpesvirus nucleoside analog dna polymerase inhibitor pharmacologic class. It is manufactured by Mylan Pharmaceuticals Inc.. For details please contact your physician.
Basic Information
- Imprint
- M;253
- Color
- White
- Shape
- Round
- Size
- 11 mm
Drug Information
- Strength
- Acyclovir 400 mg;
- Dosage Form
- Tablet
- RxCUI
- 197311
Pharmaceutical Classification
- Pharmacologic Class
- Herpesvirus nucleoside analog dna polymerase inhibitor
Related Medications
Other drugs in the same class: Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
- acyclovirACYCLOVIR 400 mg;WHITE • OVAL
- acyclovirACYCLOVIR 800 mg;WHITE • OVAL
- AcyclovirACYCLOVIR 200 mg;BLUE • CAPSULE
- AcyclovirACYCLOVIR 200 mg;LACTOSE MONOHYDRATE 195.5 mg;SODIUM STARCH GLYCOLATE TYPE A POTATO 21.15 mg;SODIUM LAURETH SULFATE 2.12 mg;MAGNESIUM STEARATE 4.23 mg;BLUE • CAPSULE
- AcyclovirAcyclovir 200 mg;Lactose Monohydrate 195.5 mg;Sodium Starch Glycolate Type A Potato 21.15 mg;Sodium Lauryl Sulfate 2.12 mg;Magnesium Stearate 4.23 mg;BLUE • OVAL
- AcyclovirACYCLOVIR 400.00 mg;WHITE • CAPSULE
- AcyclovirACYCLOVIR 400 mg;WHITE • CAPSULE
- AcyclovirACYCLOVIR 800.00 mg;WHITE • CAPSULE
- AcyclovirAcyclovir 800 mg;WHITE • OVAL
- AcyclovirACYCLOVIR 800 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Acyclovir[acyclovir];
- Inactive Ingredients
- Croscarmellose sodium;magnesium stearate;cellulose, microcrystalline;povidones;sodium lauryl sulfate;
Additional Information
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Sitavig, Xerese, Zovirax
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.